Universidad Nacional de Colombia-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2011

  1. Enhancing immunogenicity to PLGA microparticulate systems by incorporation of alginate and RGD-modified alginate

    European Journal of Pharmaceutical Sciences

2010

  1. Comparison of the adjuvanticity of two different delivery systems on the induction of humoral and cellular responses to synthetic peptides

    Drug Delivery, Vol. 17, Núm. 7, pp. 490-499

2008

  1. γ-Irradiation effects on biopharmaceutical properties of PLGA microspheres loaded with SPf66 synthetic vaccine

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 69, Núm. 2, pp. 519-526

2004

  1. Enhancing Immunogenicity and Reducing Dose of Microparticulated Synthetic Vaccines: Single Intradermal Administration

    Pharmaceutical Research, Vol. 21, Núm. 1, pp. 121-126

  2. Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles

    Vaccine, Vol. 22, Núm. 11-12, pp. 1423-1432

2003

  1. Immune response after oral administration of the encapsulated malaria synthetic peptide SPf66

    International Journal of Pharmaceutics, Vol. 260, Núm. 2, pp. 273-282

2001

  1. Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66

    Vaccine, Vol. 19, Núm. 31, pp. 4445-4451